Top 10 sessions to attend at the AMCP Annual Meeting 2016
This year’s Academy of Managed Care Pharmacy (AMCP) Managed Care & Specialty Pharmacy Annual Meeting 2016, held April 19 to 22 in San Francisco, will feature several sessions of important to managed care professionals. Here are our top 10 recommendations.
This year’s Academy of Managed Care Pharmacy (AMCP) Managed Care & Specialty Pharmacy Annual Meeting 2016, held April 19 to 22 in San Francisco, will feature a wide array of sessions. To help you create a smart itinerary, Managed Healthcare Executive Editorial Advisor David Calabrese, vice president and chief pharmacy officer, OptumRx, has identified 10 must-attend sessions.
View our Events Calendar to plan ahead for more upcoming events.
Tuesday, April 19
3:30 p.m. to 4:30 p.m.
Presented by John Nosta, president, NostaLab; and Mike A. Payne, chief commercial officer and head of medical affairs, Omada Health, Inc.
During this session, presenters will discuss how technology-supported medicine will impact specialty pharmacy in the next three years.
Wednesday, April 20
8:45 a.m. to 10:00 a.m.
Presented by: Aimee Tharaldson, PharmD,
senior clinical consultant, emerging
therapeutics, Express Scripts, Inc.
During this session, Tharaldson will discuss how specialty medications are affecting managed care pharmacy. She will focus on new and emerging specialty medications and explore their likely role in therapy.
Wednesday, April 20
10:30 a.m. to 11:45 a.m.
Presented by: Reginia Grayson Benjamin, BS, JD,
director of legislative affairs,
Academy of Managed Care Pharmacy;
and Mary Jo Carden, RPh, JD, vice president,
government and pharmacy affairs,
Academy of Managed Care Pharmacy.
During this session, presenters will provide updates on the federal and state legislative and regulatory actions of interest to pharmacists and others in managed care and specialty pharmacy.
Wednesday, April 20
12:45 p.m. to 2 p.m.
Presented by: Sharon K. Jhawar, PharmD, MBA, CGP,
corporate vice president of pharmacy,
Scan Health Plan;
and Rebecca Rabbitt, MS,
PharmD, vice president, government programs,
Medicare, Express Scripts
During this session, presenters will share best practices in designing data-driven strategies. They will share experience in implementing a pharmacy quality network pay-for-performance program to help improve member outcomes.
Wednesday, April 20
12:45 p.m. to 2 p.m.
Presented by Jeremy A. Schafer, PharmD, MBA,
vice president, director specialty solutions,
Precision For Value
During this session, presenters will compare recent safety and economic data of biosimilars through case studies of select European countries and the early experience in the US. They will also provide an outlook for biosimilars in the United States.
Wednesday, April 20
2:30 p.m. to 3:45 p.m.
Presented by Jennifer T. Chang, PharmD, MPH,
supervisor of regional drug information services,
Kaiser Permanente
During this session, Chang will provide an overview of two tools released by ASCO and NCCN and how a managed care organization utilizes these tools in the formulary review process.
Wednesday, April 20
2:30 p.m. to 3:45 p.m.
Presented by Steven G. Avey, RPh, MS, FAMCP,
vice president specialty clinical team,
MedImpact Healthcare Systems, Inc.;
Diana Brixner, RPh, PhD, FAMCP, professor,
University of Utah;
Daniel C. Malone, RPh, PhD, professor,
University of Arizona;
and Brian Sweet, AstraZeneca Pharmaceuticals.
During this presentation, presenters will share three perspectives (payer, manufacturer, societal) on how emerging therapies should be valued.
Wednesday, April 20
2:30 p.m. to 3:45 p.m.
Presented by James R. Burgdorf, PhD,
health economist, MedImpact Healthcare
Systems, Inc., and Sara Erickson, PharmD,
health outcomes researcher, MedImpact
During this session, presenters will share a new approach that shifts utilization away from high-cost generics that have lower-cost alternatives.
Thursday, April 21
8:30 a.m. to 9:45 a.m.
Presented by James R. Lang, PharmD, MBA,
vice president of pharmacy services,
Blue Cross Blue Shield of Michigan;
and Tony Schueth, MS, CEO and managing partner,
Point-of-Care Partners, LLC.
During this session, presenters will provide an overview of the prior authorization and electronic prior authorization landscapes. They will also share how the industry is addressing key barriers.
Friday, April 22
8 a.m. to 9:15 a.m.
Presented by Matthew Dull, BS,
vice president, government analytics,
Artia Solutions, LLC;
and George O. Kitchens, RPh, president,
Artia Solutions LLC.
During this presentation, presenters will provide the current landscape of Medicaid with an emphasis of recent trends such as statewide/universal preferred drug lists, prior authorizations, and 340B issues.
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
Upended: Can PBM Transparency Succeed?
March 6th 2024Simmering tensions in the pharmacy benefit management (PBM) industry have turned into fault lines. The PBMs challenging the "big three" have formed a trade association. Purchaser coalitions want change. The head of the industry's trade group says inherent marketplace friction has spilled over into political friction.
Read More
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
The deliberate disconnection of Change Healthcare to ring fence a cyberattack entered its seventh day today. Prescribers are finding ways to get pharmacy claims processed, and UnitedHealth Group says disruption to the dispensing of prescriptions has been minimal. But independent pharmacies want more information and protection from financial consequences from pharmacy benefit managers.
Read More
